These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27765537)

  • 1. Aspirin, stroke and drug-drug interactions.
    Russo NW; Petrucci G; Rocca B
    Vascul Pharmacol; 2016 Dec; 87():14-22. PubMed ID: 27765537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
    Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
    BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggrenox: a fixed-dose combination of aspirin and dipyridamole.
    Lenz TL; Hilleman DE
    Ann Pharmacother; 2000 Nov; 34(11):1283-90. PubMed ID: 11098344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of time-dependent interaction of aspirin with ibuprofen using a pharmacokinetic/pharmacodynamic model.
    Awa K; Satoh H; Hori S; Sawada Y
    J Clin Pharm Ther; 2012 Aug; 37(4):469-74. PubMed ID: 22122406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing the use of aspirin for cardiovascular prevention.
    Casado-Arroyo R; Sostres C; Lanas A
    Drugs; 2013 Jun; 73(8):803-14. PubMed ID: 23677803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of the antiplatelet combination aspirin (acetylsalicylic acid) plus extended-release dipyridamole are not altered by coadministration with the potent CYP2C19 inhibitor omeprazole.
    Offman E; Schobelock MJ; Brickl R; VanderMaelen CP; Ehrlich J; Eisert W
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):113-20. PubMed ID: 23532686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-drug interactions associated with antiplatelet therapy.
    Dunn SP; Macaulay TE
    Cardiovasc Hematol Agents Med Chem; 2011 Oct; 9(4):231-40. PubMed ID: 22023536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Glycemic Control on Efficacy of Clopidogrel in Transient Ischemic Attack or Minor Stroke Patients With
    Lin Y; Wang A; Li J; Lin J; Wang D; Meng X; Ou L; Chen W; Zhao X; Liu L; Wang Y; Wang Y;
    Stroke; 2017 Apr; 48(4):998-1004. PubMed ID: 28289237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?
    Liao JK
    Circulation; 2007 Mar; 115(12):1615-21. PubMed ID: 17389280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of non-steroidal anti-inflammatory drugs on antiplatelet effect of aspirin.
    Yokoyama H; Ito N; Soeda S; Ozaki M; Suzuki Y; Watanabe M; Kashiwakura E; Kawada T; Ikeda N; Tokuoka K; Kitagawa Y; Yamada Y
    J Clin Pharm Ther; 2013 Feb; 38(1):12-5. PubMed ID: 22882748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of the combination of aspirin with non-steroidal anti-inflammatory drugs].
    Ito N; Yokoyama H; Soeda S; Suzuki Y; Ikeda N; Tokuoka K; Watanabe M; Kitagawa Y; Yamada Y
    Yakugaku Zasshi; 2011; 131(7):1073-7. PubMed ID: 21720137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.
    Davis KA; Miyares MA; Dietrich E
    Am J Health Syst Pharm; 2015 Oct; 72(19):1623-9. PubMed ID: 26386103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the Chinese herbal medicines on dual antiplatelet therapy with clopidogrel and aspirin: Pharmacokinetics and pharmacodynamics outcomes and related mechanisms in rats.
    Xiao M; Qian C; Luo X; Yang M; Zhang Y; Wu C; Mok C; Lee P; Zuo Z
    J Ethnopharmacol; 2019 May; 235():100-110. PubMed ID: 30710735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack.
    Scalia L; Calderone D; Capodanno D
    Expert Rev Clin Pharmacol; 2022 Sep; 15(9):1027-1038. PubMed ID: 36031827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of mean arterial pressure on the efficacy and safety of dual antiplatelet therapy in minor stroke or transient ischemic attack patients.
    Ma Y; Liu Y; Xu J; Wang Y; Du F; Wang Y
    J Clin Hypertens (Greenwich); 2019 May; 21(5):598-604. PubMed ID: 30957391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke.
    Hilkens NA; Algra A; Diener HC; Bath PM; Csiba L; Hacke W; Kappelle LJ; Koudstaal PJ; Leys D; Mas JL; Sacco RL; Greving JP
    Stroke; 2021 Oct; 52(10):3258-3265. PubMed ID: 34304604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline.
    Prasad K; Siemieniuk R; Hao Q; Guyatt G; O'Donnell M; Lytvyn L; Heen AF; Agoritsas T; Vandvik PO; Gorthi SP; Fisch L; Jusufovic M; Muller J; Booth B; Horton E; Fraiz A; Siemieniuk J; Fobuzi AC; Katragunta N; Rochwerg B
    BMJ; 2018 Dec; 363():k5130. PubMed ID: 30563885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.
    Pan Y; Elm JJ; Li H; Easton JD; Wang Y; Farrant M; Meng X; Kim AS; Zhao X; Meurer WJ; Liu L; Dietrich D; Wang Y; Johnston SC
    JAMA Neurol; 2019 Dec; 76(12):1466-1473. PubMed ID: 31424481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
    Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
    Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.